ObsEva (MEX:OBSN N) EBIT: MXN-383.6 Mil (TTM As of Dec. 2022)


MEX:OBSN N ObsEva SA MEX:OBSN N
18 GF Score
Price MXN1.70
View Full Analysis

What is ObsEva EBIT?

ObsEva MEX:OBSN N 18 EBIT is MXN-383.6 Mil as of Dec. 2022. GuruFocus rates MEX:OBSN N with a GF Score™ of 18/100.

ObsEva's earnings before interest and taxes (EBIT) for the three months ended in Dec. 2022 was MXN613.9 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2022 was MXN-383.6 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. ObsEva's annualized ROC % for the quarter that ended in Dec. 2022 was 265.71%. ObsEva's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was 6,288.13%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. ObsEva's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2022 was 430.80%.

ObsEva  (MEX:OBSN N) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

ObsEva's annualized ROC % for the quarter that ended in Dec. 2022 is calculated as:

ROC % (Q: Dec. 2022 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Sep. 2022 ) + Invested Capital (Q: Dec. 2022 ))/ count )
=590.028 * ( 1 - 0% )/( (318.44 + 125.672)/ 2 )
=590.028/222.056
=265.71 %

where

Invested Capital(Q: Sep. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=338.073 - 165.909 - ( 194.794 - max(0, 378.866 - 232.59+194.794))
=318.44

Invested Capital(Q: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=322.542 - 32.636 - ( 164.234 - max(0, 140.098 - 311.8+164.234))
=125.672

Note: The Operating Income data used here is four times the quarterly (Dec. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

ObsEva's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2022 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2022 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Sep. 2022  Q: Dec. 2022
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=2455.796/( ( (7.201 + max(-154.624, 0)) + (4.426 + max(66.482, 0)) )/ 2 )
=2455.796/( ( 7.201 + 70.908 )/ 2 )
=2455.796/39.0545
=6,288.13 %

where Working Capital is:

Working Capital(Q: Sep. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(0 + 0 + 37.796) - (165.909 + 0 + 26.511)
=-154.624

Working Capital(Q: Dec. 2022 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(4.913 + 0 + 142.653) - (32.636 + 0 + 48.448)
=66.482

When net working capital is negative, 0 is used.

Note: The EBIT data used here is four times the quarterly (Dec. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

ObsEva's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2022 )
=-383.589/-89.041
=430.80 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ObsEva EBIT Related Terms

ObsEva EBIT Historical Data

* Premium members only.

The historical data trend for ObsEva's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ObsEva EBIT Chart

ObsEva Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
EBIT
Get a 7-Day Free Trial Premium Member Only -1,507.20 -2,028.15 -1,595.90 -1,012.16 -402.40

ObsEva Quarterly Data
Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -277.02 -172.65 -631.44 -193.45 613.95

MEX:OBSN N vs VRTX, REGN, SGEN: EBIT Comparison

For the Biotechnology subindustry, ObsEva's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

ObsEva EV-to-EBIT vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ObsEva's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where ObsEva's EV-to-EBIT falls into.


MEX:OBSN N
18GF Score
ObsEva SA MEX:OBSN N
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ObsEva EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2022 adds up the quarterly data reported by the company within the most recent 12 months, which was MXN-383.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of MXN-383.6 Mil mean?
ObsEva (MEX:OBSN N) has a EBIT of MXN-383.6 Mil as of Dec. 2022. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on ObsEva.
Is ObsEva's EBIT too high?
ObsEva's current EBIT is MXN-383.6 Mil. Overall, ObsEva has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does ObsEva's EBIT compare to VRTX and REGN?
ObsEva's EBIT of MXN-383.6 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Biotechnology company?
A good EBIT depends on the Biotechnology industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on ObsEva. ObsEva's current EBIT is MXN-383.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ObsEva stock overvalued right now?
ObsEva (MEX:OBSN N) has a current EBIT of MXN-383.6 Mil. The current EBIT is MXN-383.6 Mil. ObsEva's overall GF Score™ is 18/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For ObsEva (MEX:OBSN N), the current EBIT is MXN-383.6 Mil as of Dec. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ObsEva Business Description

Address Chemin des Aulx, 12, Plan-les-Ouates, Geneva, CHE, 1228
ObsEva SA is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. The Company operates in one segment, which is the research and development of women's reproductive, health, and pregnancy therapeutics. It includes advancing a development program for Nolasiban, an oral oxytocin receptor agonist, focused on improving clinical pregnancy and live birth rates in women undergoing in-vitro fertilization (IVF). Geographically, the majority is from Switzerland.
18GF Score

Get the complete analysis for MEX:OBSN N

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN1.70
Price